After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Linvoseltamab BLA for Treatment of Relapsed/Refractory Multiple Myeloma Accepted for FDA Priority Review.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Regeneron Pharmaceuticals, Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $964.89 and fluctuated between $973.00 as its day high and $947.85 as its day low. The current market capitalization of Regeneron Pharmaceuticals, Inc. is $105.91B. A total of 0.6 million shares were traded on the day, compared to an average of 563.79K shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, REGN has seen 0 BUY and 3 SELL insider trades, representing the acquisition of 0 and the disposition of 1,930 shares. Over the last 12 months, there were 20 BUYs and 146 SELLs from insiders. Insiders purchased 191,746 shares during that period but sold 224,081.
In the most recent transaction, Van Plew Daniel P sold 10,434 shares of REGN for 942.28 per share on Feb 14. After the transaction, the EVP & General Mgr, Industrial now owns 20,378 company shares. In a previous transaction on Feb 09, Fenimore Christopher R. sold 4,919 shares at 953.31 per share. REGN shares that SVP Finance & CFO owns now total 14,372.
Among the insiders who sold shares, SING GEORGE L disposed of 500 shares on Feb 09 at a per-share price of $955.00. This resulted in the Director holding 26,349 shares of REGN after the transaction. In another insider transaction, SING GEORGE L sold 500 shares at $945.00 per share on Feb 08. Company shares held by the Director now total 26,349.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for REGN in the last 3 months, the mean price target is $1,022.87 with high estimates of $1,152.00 and low estimates of $710.00. In terms of 52-week highs and lows, REGN has a high of $973.99 and a low of $684.80.
As of this writing, REGN has an earnings estimate of $10.02 per share for the current quarter. EPS was calculated based on a consensus of 18 estimates, with a high estimate of $12.34 per share and a lower estimate of $8.41. The company reported an EPS of $11.59 in the last quarter, which was 8.10% higher than expectations of $10.72.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. REGN’s latest balance sheet shows that the firm has $5.69B in Cash & Short Term Investments as of fiscal 2021. There were $2.70B in debt and $3.93B in liabilities at the time. Its Book Value Per Share was $237.41, while its Total Shareholder’s Equity was $18.77B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for REGN is Buy with a score of 4.45.
